TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
RLYB

Rallybio Corp

Healthcare · Biotechnology

17.20$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RLYB
Line item 2019 2020 2021 2022 2023 2024 2025
– +556.5% +28.4% -1.0% -35.9% -41.1% -8.6%
– +575.2% +28.0% -0.8% -36.0% -40.9% -9.7%
– +620.7% +25.0% -67.5% -57.0% -43.2% +125.7%
– +620.7% +25.0% -3.6% -35.0% -40.4% -16.4%
– +44.2% +78.0% -24.7% – – –
– +23.3% +12.4% +68.9% -15.1% -31.6% -33.3%
– +53.5% +12.1% +64.0% -13.8% -32.6% -32.3%
– – – – +21.0% -29.7% -39.0%
– +84.2% -61.8% +84.7% -12.4% -71.5% -54.7%
– +706.7% +29.1% -3.6% -37.3% -41.9% -6.0%
– – – – – – –
– +0.0% +44.4% -1.0% +27.1% +7.7% +3.4%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?